Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: FDA OKs expanded access for stem cell therapy

By admin
Created May 8 2008 - 5:59am


Osiris Therapeutics has won approval for an expanded access treatment program for Prochymal, making the Phase III stem cell therapy for graft-vs-host-disease available to children. Osiris release [1]

Source URL: http://www.fiercebiotech.com/story/spotlight-fda-oks-expanded-access-for-stem-cell-therapy/2008-05-08

Links:
[1] http://www.fiercebiotech.com/press-releases/osiris-therapeutics-receives-approval-use-prochymal-tm-under-fda-expanded-access-trea